Read the latest news about Healx and our goal to advance treatments for rare diseases.
Kate has extensive expertise in drug discovery and her appointment underlines our mission to combine deep pharmacological expertise with Artificial Intelligence
Healx scientists, in a study led by Erin Oerton, have evaluated different types of biological information for their value of relating diseases to each in other, in a publication that has just appeared in the journal Bioinformatics. The study took six different types of data sets into account, namely ontological, phenotypic, literature co-occurrence, genetic association, gene … Continued
We are delighted to announce $10 million Series A funding round, led by Balderton Capital. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.
The Business Weekly article also covers the appointment of Shaun Grady, a leading business development executive at Astra Zeneca, to Healx’s board of directors
Erin Oerton, a PhD student at the University of Cambridge and data scientist at Healx, has won the poster prize for the Systems Medicine track at the 2nd Interdisciplinary Signalling Workshop in Visegrad, Hungary.